Question 1

Has Stephen Hughes received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $682,684 in general payments to Stephen Hughes across 905 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Stephen Hughes did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Stephen Hughes come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	352	$269,083
Otsuka America Pharmaceutical, Inc.	273	$222,636
Alkermes, Inc.	164	$115,271
AbbVie(2 entities)	78	$62,523
Indivior Inc.	16	$9,375
E.r. Squibb & Sons, L.L.C.	1	$1,840
Otsuka Pharmaceutical Development & Commercialization, Inc.	9	$862
Sunovion Pharmaceuticals Inc.	3	$339
Avanir Pharmaceuticals, Inc.	2	$216
Lundbeck LLC	3	$152
Tris Pharma Inc	1	$123
Neurocrine Biosciences, Inc.	1	$117
Johnson & Johnson	1	$100
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$47

Stephen Hughes

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Birmingham